Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Heroin Dependence, Opioid-Related Disorders

In brief

Heroin addiction is a growing problem in Russia; individuals who enter heroin addiction treatment often relapse. Therefore, effective heroin addiction treatments are necessary to prevent relapse. The purpose of this study is to compare oral naltrexone with a naltrexone implant that provides opioid blockade for two months in preventing relapse to heroin addiction in St. Petersburg, Russia.

Key facts

Study ID

NCT00218426

Run by

University of Pennsylvania

People needed

306

Starts

2006-07-01

Expected to finish

2010-11-04

Last updated by the study team

2019-03-18

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current opioid dependence
• Recently completed opioid detoxification

You may not qualify if…

• Serious medical or psychiatric condition requiring immediate hospitalization or that would make participation in the study hazardous
• Planning to leave the study area within the 12 months following study entry
• Imminent incarceration
• Pregnancy

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Pavlov Medical University — Saint Petersburg, Russia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.